Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase NA × Neuroendocrine Tumors × Palliative Care × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

NET 1 Endocrine 1

Conditions

Breast Neoplasms 18 Neoplasms 13 Ovarian Neoplasms 7 Leukemia, Myeloid, Acute 7 Lymphoma 6 Lung Neoplasms 6 Neoplasm Metastasis 5 Multiple Myeloma 5 Hematologic Neoplasms 5 Prostatic Neoplasms 4 Leukemia 4 Fatigue 4 Colorectal Neoplasms 4 Vulvar Neoplasms 3 Uterine Cervical Neoplasms 3 Sarcoma 3 Pancreatic Neoplasms 3 Myelodysplastic Syndromes 3 Glioblastoma 3 Depression 3 Anxiety Disorders 3 Vaginal Neoplasms 2 Urinary Bladder Neoplasms 2 Stomach Neoplasms 2 Rectal Neoplasms 2 Precursor Cell Lymphoblastic Leukemia-Lymphoma 2 Peritoneal Neoplasms 2 Pain 2 Motor Activity 2 Melanoma 2

Interventions

lutetium Lu 177 dotatate 2 Lutetium-177 2 Liquid Biopsy 2 pentetreotide 1 fluorodopa F 18 1 copper dotatate CU-64 1 Yttrium-90 1 Surveys and Questionnaires 1 Surgical Procedures, Operative 1 Standard of Care 1 Specimen Handling 1 Single Photon Emission Computed Tomography Computed Tomography 1 Resveratrol 1 Respiratory Therapy 1 Referral and Consultation 1 Quality of Life 1 Poly(ADP-ribose) Polymerase Inhibitors 1 Palliative Care 1 Nutrition Assessment 1 Needles 1 Magnetic Resonance Spectroscopy 1 Endoscopic Mucosal Resection 1 Diet Therapy 1 Data Collection 1 Cryosurgery 1 Control Groups 1 Colectomy 1 Betaine 1 90Y-octreotide, DOTA-Tyr(3)- 1 3-Iodobenzylguanidine 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT01849523 2024-05-06

WIN

University Medical Center Groningen

Phase NA Completed

Neuroendocrine Tumors

Data powered by HemOnc (CC BY 4.0) Colophon ⚡